Molecular mechanisms for the antitumor activity of inositol hexakisphosphate (IP6)

Anikó Bozsik1, Szabolcs Kökény, Edith Olah

  • 1National Institute of Oncology, Department of Molecular Genetics, Budapest, H-1122, Hungary.

Abstract

Insights

Inositol hexakisphosphate (IP6) inhibits leukemia cell growth by inducing differentiation and apoptosis. This study reveals IP6 modulates key signaling pathways, offering insights into its anticancer effects.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Inositol hexakisphosphate (IP6) exhibits anticancer properties against various tumors.
  • The precise molecular mechanisms underlying IP6's anticancer activity remain largely unelucidated.

Purpose of the Study:

  • To investigate the molecular mechanisms of IP6's anticancer effects in K-562 human leukemia cells.
  • To analyze the induction of erythroid differentiation and gene expression modulation by IP6.

Main Methods:

  • K-562 human leukemia cells were treated with IP6.
  • Oligonucleotide microarrays and quantitative real-time PCR (Q-PCR) were employed to analyze gene expression profiles.
  • Erythroid differentiation was assessed via hemoglobin synthesis and benzidine staining.

Main Results:

  • IP6 demonstrated dose- and time-dependent inhibition of K-562 cell growth.
  • IP6 treatment activated the erythroid differentiation program and modulated approximately 1800-1200 transcripts.
  • Gene expression analysis revealed IP6's association with immunity, Wnt, IGF, PI3 kinase pathways, and apoptosis, with a 2-fold upregulation of the apoptosis pathway (BAX/BCL-2 ratio).
  • IP6 significantly increased hemoglobin synthesis, with up to 70% benzidine-positive cells at 120 hours.

Conclusions:

  • IP6 acts as a potent inducer of differentiation (cytostatic) and a moderate inducer of apoptosis (cytotoxic).
  • The growth-inhibitory effects of IP6 are mediated through the modulation of critical cellular signaling pathways.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...